The DOI matches its Crossref record, with a small difference in title or year; 46 of the 47 references it cites were found in a registry or an index.
Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses
Open accessAbstract
Although beta-amyloid (Abeta) plaques and tau neurofibrillary tangles are hallmarks of Alzheimer's disease (AD) neuropathology, loss of synapses is considered the best correlate of cognitive decline in AD, rather than plaques or tangles. How pathological Abeta and tau aggregation relate to each other and to alterations in synapses remains unclear. Since aberrant tau phosphorylation occurs in amyloid precursor protein (APP) Swedish mutant transgenic mice, and since neurofibrillary tangles develop in triple transgenic mice harboring mutations in APP, tau and presenilin 1, we utilized these well-characterized mouse models to explore the relation between Abeta and tau pathologies. We now report that pathological accumulation of Abeta and hyperphosphorylation of tau develop concomitantly within synaptic terminals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A number of studies have associated intraneuronal Ab buildup with hyperphosphorylation of tau protein, 8 disturbed protein trafficking and sorting, 9 reduced expression of synaptic proteins, 10 and mitochondrial dysfunction.11,12”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 2×
“…et al., 2002; Cataldo et al., 2004; Gouras et al., 2000; Gyure et al., 2001; Mori et al., 2002), and transgenic AD mouse models (Lord et al., 2006; Oakley et al., 2006; Oddo et al., 2003; Sheng et al., 2003; Shie et al., 2003; Stokin et al., 2005; Takahashi et al., 2002; Van Broeck et al.,…”
BackgroundIntracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–151 of 151
Current Progress and Future Directions in Non-Alzheimer’s Disease Tau PET Tracers
Wongso, H., Harada, R., & Furumoto, S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00319 · Cited by 13
Bhullar, K. S., & Rupasinghe, H. P. V. (2015) · Food Research International · doi:10.1016/j.foodres.2015.05.019 · Cited by 13
Interactions with tau’s microtubule-binding repeats modulate amyloid-β aggregation and toxicity
Kim, M., Lin, Y., Nam, E., Kang, D. M., Lim, S., Kim, Y. K., Lee, Y., & Lim, M. H. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01987-0 · Cited by 15
Age-dependent microstructure alterations in 5xFAD mice by high-resolution diffusion tensor imaging
Maharjan, S., Tsai, A. P., Lin, P. B., Ingraham, C., Jewett, M. R., Landreth, G. E., Oblak, A. L., & Wang, N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.964654 · Cited by 15
Alzheimer’s Aβ catalyzes Tau phase separation and aggregation via early nanocluster solubilization
Sun, X., Tang, Y., Wang, X., Curia, G. P., Sternke‐Hoffmann, R., Mörman, C., Gerez, J., Riek, R., Wei, G., & Luo, J. (2026) · Nature Communications · doi:10.1038/s41467-026-70083-1 · Cited by 11
A novel structure associated with aging is augmented in the DPP6-KO mouse brain
Lin, L., Petralia, R. S., Lake, R. G., Wang, Y., & Hoffman, D. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01065-7 · Cited by 11
Conductance-Based Structural Brain Connectivity in Aging and Dementia
Frau‐Pascual, A., Augustinack, J. C., Varadarajan, D., Yendiki, A., Salat, D. H., Fischl, B. R., Aganj, I., & Initiative, A. D. N. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0903 · Cited by 10
The phospholipase A2 pathway controls a synaptic cholesterol ester cycle and synapse damage
Osborne, C., West, E., & Bate, C. (2018) · Journal of Cell Science · doi:10.1242/jcs.211789 · Cited by 9
Aging, Metabolism, Synaptic Activity, and Aβ in Alzheimer's Disease
Gouras, G. K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00185 · Cited by 10
Self-citationPark, S., Park, M., & Lee, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118472 · Cited by 12
Sheng, C., Xu, P., Liu, X., Peng, W., Xiang, D., & Luo, S. (2020) · Neural Plasticity · doi:10.1155/2020/8874885 · Cited by 8
Role of Neurexins in Alzheimer's Disease
Medina-Samamé, A., Paller, É., Bril, M. R., Archvadze, A., Simões-Abade, M. B. C., Cayuela, P. E., & LeMaoult, C. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0169-23.2023 · Cited by 8
Hall, Z., Chien, B., Zhao, Y., Risacher, S. L., Saykin, A. J., Wu, Y., & Wen, Q. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00531-7 · Cited by 7
Hsieh, S., Liu, M., Huang, L., Wu, M., & Yang, Y. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200103114550 · Cited by 7
Emmerson, J. T., Carmo, S. D., Lavagna, A., Huang, C., Wong, T. P., Martínez-Trujillo, J., & Cuello, A. C. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01901-0 · Cited by 5
Mezias, C., & Raj, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.06.371625 · Cited by 5
Identifying stage of Alzheimer disease using multiclass particle swarm optimisation technique
Jiji, G. W. (2018) · Journal of Experimental & Theoretical Artificial Intelligence · doi:10.1080/0952813x.2018.1509380 · Cited by 5
Torok, J., Mezias, C., & Raj, A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70092 · Cited by 3
A lifespan staging model of basal forebrain cholinergic vulnerability
Shanks, H. R. C., Chen, S., Onuska, K. M., & Schmitz, T. W. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71380 · Cited by 3
Liu, T., & Li, X. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70460 · Cited by 3
Alzheimer’s Disease: Causes, Mechanisms, and Steps Toward Prevention
Choi, S. H., & Tanzi, R. E. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190069162.013.18 · Cited by 3
Kong, J., So, M., Park, H., Kim, Y.-T., Kim, H., Pahk, K., Kang, S. H., Do, S., Lim, D.-K., Lee, C., et al. (2025) · Clinical Neurophysiology · doi:10.1016/j.clinph.2025.2111374 · Cited by 2
Immunotherapy for Alzheimer disease
Gouras, G. K. (2009) · mAbs · doi:10.4161/mabs.1.2.7829 · Cited by 2
Self-citationAmyloid β–dependent neuronal silencing through synaptic decoupling
Zhang, Y., Chen-Engerer, H.-J., Zhang, K., Zott, B., Varga, Z., Chen, Y., Chen, X., Hongbo, J., Sakmann, B. J., Nelken, I., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2515113122 · Cited by 2
Drug repurposing in Alzheimer's disease: Emerging therapeutic strategies and promising candidates
More, P. S., Rangari, S. W., Lade, S. N., Unidrwade, D. S., Burle, S. S., Umekar, M. J., Lohiya, R. T., & Zanwar, A. S. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103113 · Cited by 1
Nanoparticles-induced brain injury: prevalence, mechanisms, and implications
Boukholda, K., Olojede, S. O., Slimen, S. B., Elbayoumi, E., Dhaouadi, N., Alabi, B. A., Lawal, S. K., Elwej, A., Maman, M. P., Fetoui, H., et al. (2026) · Environmental Sciences Europe · doi:10.1186/s12302-026-01369-w · Cited by 1
A Study on Alzheimer’s Disease
Kaushik, A., & Singh, J. (2019) · International Journal of Computer Applications · doi:10.5120/ijca2019918589 · Cited by 1
ROLE OF SOD AND CATHEPSIN-D IN ALZHEIMER’S DISEASE Aβ CASCADE MODELS
Lobdell, G. M., & Donahue, M. K. (2011) · Digital WPI · Cited by 1
Prion Protein Misfolding at the Synapse
Šišková, Z., Perry, V. H., & Asuni, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7061-9_15 · Cited by 1
Downer, B. G. (2014) · UKnowledge (University of Kentucky)
Neuroprotective Properties of Partridgeberry (Vaccinium vitis-idaea L. var. minus Lodd) Polyphenols
Bhullar, K. S. (2014) · DalSpace (Dalhousie University)
Lin, M. (2010)
Self-citationPathological Consequences of Aβ From Extracellular to Intraneuronal
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00004-8
Intraneuronal Amyloid and Plaque Formation
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00005-x
Gonzalez, B. L. (2016) · eScholarship (California Digital Library)
Cognitive Deficits in Neurodegenerative Disorders: Parkinson’s Disease and Alzheimer’s Disease
Bodis-Wollner, I. G., & Moreno, H. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_9
Remnestål, J., Bergström, S., Olofsson, J., Sjöstedt, E., Uhlén, M., Blennow, K., Zetterberg, H., Zettergren, A., Kern, S., Skoog, I. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150846
Remnestål, J., Bergström, S., Olofsson, J., Sjöstedt, E., Uhlén, M., Blennow, K., Zetterberg, H., Zettergren, A., Kern, S., Skoog, I. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150870
Remnestål, J., Bergström, S., Olofsson, J., Sjöstedt, E., Uhlén, M., Blennow, K., Zetterberg, H., Zettergren, A., Kern, S., Skoog, I. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150861
Remnestål, J., Bergström, S., Olofsson, J., Sjöstedt, E., Uhlén, M., Blennow, K., Zetterberg, H., Zettergren, A., Kern, S., Skoog, I. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150852
Additional file 2 of A novel structure associated with aging is augmented in the DPP6-KO mouse brain
Lin, L., Petralia, R. S., Lake, R. G., Wang, Y.-X., & Hoffman, D. A. (2020) · Figshare · doi:10.6084/m9.figshare.13278821
Remnestål, J., Bergström, S., Olofsson, J., Sjöstedt, E., Uhlén, M., Blennow, K., Zetterberg, H., Zettergren, A., Kern, S., Skoog, I. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150858
Remnestål, J., Bergström, S., Olofsson, J., Sjöstedt, E., Uhlén, M., Blennow, K., Zetterberg, H., Zettergren, A., Kern, S., Skoog, I. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150843
Remnestål, J., Bergström, S., Olofsson, J., Sjöstedt, E., Uhlén, M., Blennow, K., Zetterberg, H., Zettergren, A., Kern, S., Skoog, I. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150855
Remnestål, J., Bergström, S., Olofsson, J., Sjöstedt, E., Uhlén, M., Blennow, K., Zetterberg, H., Zettergren, A., Kern, S., Skoog, I. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150849
Remnestål, J., Bergström, S., Olofsson, J., Sjöstedt, E., Uhlén, M., Blennow, K., Zetterberg, H., Zettergren, A., Kern, S., Skoog, I. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150864
Additional file 1 of A novel structure associated with aging is augmented in the DPP6-KO mouse brain
Lin, L., Petralia, R. S., Lake, R. G., Wang, Y.-X., & Hoffman, D. A. (2020) · Figshare · doi:10.6084/m9.figshare.13278818
Remnestål, J., Bergström, S., Olofsson, J., Sjöstedt, E., Uhlén, M., Blennow, K., Zetterberg, H., Zettergren, A., Kern, S., Skoog, I. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150867
Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c
Caractérisation d'anticorps à domaine unique dirigés contre la protéine Tau
Danis, C. (2018) · theses.fr (ABES) · doi:10.70675/c783a062zb57bz4024z85d0z509baaed8a1b
Metadata
- Authors
- Takahashi, R. H., Capetillo-Zarate, E., Lin, M. T., Milner, T. A., & Gouras, G. K.
- Affiliations
- Weill Cornell Medicine (US)
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 31
- Issue
- 7
- Pages
- 1145-1152
- ISSN
- 0197-4580 (ISSN-L)
- PMC
- PMC2909664
- OpenAlex
- W2000668585
- Cited by
- 150
- References
- 47
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 1 · 2023: 1 · 2022: 6 · 2021: 18 · 2020: 15 · 2019: 3 · 2018: 9 · 2017: 12 · 2016: 6 · 2015: 9 · 2014: 13 · 2013: 10 · 2012: 3
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- University of Minnesota
- National Institutes of Health
- National Institute on Aging (R01AG027140, K02AG028174, AG028174, AG027140)
- National Heart, Lung, and Blood Institute (HL-18974, P01HL018974)
- National Institute of Neurological Disorders and Stroke (R01NS045677, NS 045677)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, tau hyperphosphorylation, synapses, synaptic loss, amyloid plaques, neurofibrillary tangles, triple transgenic mice, presenilin 1
- MeSH terms
- Adult, Alzheimer Disease, Animals, Disease Models, Animal, Humans, Mice, Transgenic, Middle Aged, Peptide Fragments, Phosphorylation, Amyloid beta-Peptides, tau Proteins, Presynaptic Terminals, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
